Benitec Biopharma Inc. (BNTC) Misses Q2 EPS by 9c

Benitec Biopharma Inc. (NASDAQ: BNTC) reported Q2 EPS of ($0.20), $0.09 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Benitec Biopharma Inc. (BNTC) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• UBS Reiterates Buy Rating on Smurfit Westrock (SW)
• Tradeweb Markets (TW) PT Lowered to $151 at Raymond James